LukS-PV Inhibits Hepatocellular Carcinoma Cells Migration via the TNNC1/PI3K/AKT Axis

Garcinol acts as an antineoplastic agent in human gastric cancer by inhibiting the PI3K/AKT signaling pathway

(2020) Yuanyuan Zheng et al.   Oncology Letters

LukS-PV inhibits hepatocellular carcinoma progression by downregulating HDAC2 expression

(2020) Ziran Wang et al.   Molecular Therapy-Oncolytics

Identification of prognostic and metastasis-related alternative splicing signatures in hepatocellular carcinoma

(2020) Runzhi Huang et al.   BIOSCIENCE REPORTS

MicroRNA-134 inhibits tumor stem cell migration and invasion in oral squamous cell carcinomas via downregulation of PI3K-Akt signaling pathway by inhibiting LAMC2 expression

(2020) Yong-Mei Zhou et al.   Cancer Biomarkers

MicroRNA-34a inhibits cell invasion and epithelial-mesenchymal transition via targeting AXL/PI3K/AKT/Snail signaling in nasopharyngeal carcinoma

(2020) Chengyi Jiang et al.   Genes & Genomics

MicroRNA-196a promotes cell proliferation and inhibits apoptosis in human ovarian cancer by directly targeting DDX3 and regulating the PTEN/PI3K/AKT signaling pathway

(2020) Jie Ni et al.   Molecular Medicine Reports

Puerarin 6″‐O‐xyloside suppressed HCC via regulating proliferation, stemness, and apoptosis with inhibited PI3K/AKT/mTOR

(2020) Long Li et al.   Cancer Medicine

lncRNA TM4SF1-AS1 Activates the PI3K/AKT Signaling Pathway and Promotes the Migration and Invasion of Lung Cancer Cells

(2020) Fachen Zhou et al.   Cancer Management and Research

LukS‐PV induces apoptosis in acute myeloid leukemia cells mediated by C5a receptor

(2019) Peng Zhang et al.   Cancer Medicine

Quantitative proteomic analysis reveals that Luks-PV exerts antitumor activity by regulating the key proteins and metabolic pathways in HepG2 cells

(2019) Chang-Cheng Zhao et al.   ANTI-CANCER DRUGS

CEP55 promotes the proliferation, migration and invasion of esophageal squamous cell carcinoma via the PI3K/Akt pathway

(2018) Yang Jia et al.   OncoTargets and Therapy

GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses

(2017) Zefang Tang et al.   NUCLEIC ACIDS RESEARCH

MFAP5 and TNNC1: Potential markers for predicting occult cervical lymphatic metastasis and prognosis in early stage tongue cancer

(2016) Xi Yang et al.   Oncotarget

LukS-PV, a component of Panton-Valentine leukocidin, exerts potent activity against acute myeloid leukemia in vitro and in vivo

(2015) Wulin Shan et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Prognosis of untreated hepatocellular carcinoma

(2014) Edoardo G. Giannini et al.   HEPATOLOGY

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

(2014) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Calcium-dependent FAK/CREB/TNNC1 signalling mediates the effect of stromal MFAP5 on ovarian cancer metastatic potential

(2014) Cecilia S. Leung et al.   Nature Communications

Cytotoxicity of Bacterial Metabolic Products, including Listeriolysin O, on Leukocyte Targets

(2012) R. Stachowiak et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

A Deimmunized Bispecific Ligand-Directed Toxin That Shows an Impressive Anti–Pancreatic Cancer Effect in a Systemic Nude Mouse Orthotopic Model

(2012) Seunguk Oh et al.   PANCREAS

Staphylococcal Panton-Valentine Leukocidin Induces Pro-Inflammatory Cytokine Production and Nuclear Factor-Kappa B Activation in Neutrophils

(2012) Xiaoling Ma et al.   PLoS One

A guide to taming a toxin - recombinant immunotoxins constructed from Pseudomonas exotoxin A for the treatment of cancer

(2011) John E. Weldon et al.   FEBS Journal

Functional Characterization ofTNNC1Rare Variants Identified in Dilated Cardiomyopathy

(2011) Jose Renato Pinto et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Targeting Tumor-Initiating Cancer Cells with dCD133KDEL Shows Impressive Tumor Reductions in a Xenotransplant Model of Human Head and Neck Cancer

(2011) N. N. Waldron et al.   MOLECULAR CANCER THERAPEUTICS

Treatment of Intermediate/Advanced Hepatocellular Carcinoma in the Clinic: How Can Outcomes Be Improved?

(2010) R. Lencioni et al.   ONCOLOGIST

VEGFA Upregulates FLJ10540 and Modulates Migration and Invasion of Lung Cancer via PI3K/AKT Pathway

(2009) Chang-Han Chen et al.   PLoS One

Systemic therapy of hepatocellular carcinoma: Are we making progress?

(2008) Patricia Roxburgh et al.   ADVANCES IN THERAPY